期刊文献+

头孢类抗生素残留检测方法及环境风险评估研究 被引量:2

Detection Method and Environmental Risk Assessment of Cephalosporin AntibioticsResiduals
下载PDF
导出
摘要 基于固相萃取-超高效液相色谱/电喷雾离子源/三重四级杆串联质谱技术,建立了水中头孢唑林和头孢呋辛的测试方法。目标物的检出限分别为5 ng/L和2 ng/L。在0.5~50μg/L范围内线性良好(r〉0.990)。利用该技术,检测一污水处理厂的入口水、出口水和入河口的目标物残留,入口水的平均浓度分别为:34.3μg/L和27.7μg/L,出口水的平均浓度分别为1.19μg/L和1.27μg/L,入河口的平均浓度分别为0.11μg/L和0.05μg/L。风险商值法评估入河口中残留的头孢呋辛为高风险等级。 Based on solid extraction-ultra performance liquid chromatography-electrospray ionization-tandem mass spectrometyr( SPE-UPLC-ESI / MS / MS),a testing method for cefazolin and cefuroximein water was established. The detection limits of samples were 5ng / L and 2ng / L respectively. The correlation coefficient of the calibration curve was good( r 〉0. 990). With this method,theresiduals in the influent,effluent of a wastewater treatment plant and the estuarywere tested. Their average concentrations in influent were 34. 3 μg / L and 27. 7 μg / L,in the effluent were 1. 19 μg / L and 1. 27 μg / L,and in the estuary were0. 11 μg / L and 0. 05 μg / L,respectively. Risk quotient method was utilized to evaluate the environmental risk of these two antibiotics in the estuary,and cefuroxime was at high risk level.
出处 《环境科学与管理》 CAS 2015年第11期144-146,共3页 Environmental Science and Management
关键词 头孢类抗生素 SPE-UPLC/MS/MS 环境风险评价 cephalosporin antibiotics SPE-UPLC-ESI / MS / MS environmental risk assessment
  • 相关文献

参考文献8

  • 1KiimmererK. Significance of antibiotics in the environ-ment [J]. J. Antimicrobial Chemotherapy,2003,52:527 - 531.
  • 2Liu. F, YingG. G, YangJ. F, et al. Dissipation of sulfa- methoxazole, trimethoprim and tylosin in a soil under aerobic and anoxic conditions [J]. Environ. Chem ,2010,7 (4) :370 - 376.
  • 3Kim S, Cho J, Kim IS. Occurrence and removal of pharmaceuticals and endocrine disruptors in south korean surface drinking and wastewaters [J]. Wat Res,2007,41:1013 - 1021.
  • 4Ktlmmerer K. Antibiotics in the aquatic environment a review Part I[J].Chemosphere,2009,75:417 -434.
  • 5Fent K, Escher C, Caminada D. Estrogenic activity of pharmaceuticals and pharmaceutical mixtures in a yeast reporter gene system [J]. Reproductive Toxicology,2006,22 : 175 - 185.
  • 6薛雨,陈宇瑛.头孢菌素类抗生素的最新研究进展[J].中国抗生素杂志,2011,36(2):86-92. 被引量:92
  • 7Xiao - HuanWang, Angela Yu -Chen Hn. Phototransfor- marion of Cephalosporin Antibiotics in an Aqueous Environment Results in Higher Toxicity. EnvironmentScience&Technology [J], 2012,46:12417 - 12426.
  • 8Kummerer K, Henninger A. Promoting resistance by the emission of antibiotics from hospitals and households into ef- fluent [J]. Clinical Microbiology and Infection, 2003,9 ( 12 ) : 1203 - 1214.

二级参考文献14

  • 1张致平.抗生素结构修饰的进展[J].中国抗生素杂志,2006,31(2):90-99. 被引量:9
  • 2刘家健.头孢菌素类品种研发与生产现状探讨[J].中国抗生素杂志,2006,31(2):100-106. 被引量:17
  • 3Jack J C, Theresa M B, Joseph T W, et al. Randomized, prospective comparison of first-and second-generation cephalosporins as infection prophylaxis for cardiac surgery[J]. Am JSurg, 1993, 166(6): 734-737.
  • 4Stuart M H. Pharmacokinetics of the third-generation cephalosporins[J]. Am J Med, 1985, 79(2): 21-24.
  • 5Emirhan N, Sedef K, Doruk K, et al. Simultaneous roultiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: Application to validation and quantification of cefepime, cefixime and cefoperazone[J]. Talanta, 2009, 80(1): 117-126.
  • 6Yoshizawa H, Kubota T, Itani H, et al. New broad-spectrum parenteral cephalosporins exhibiting potentactivity against both methicillin-resistant Staphylococcus aureus(MRSA ) and Pseudomonas aeruginosa. Part 2: Synthesis and Structure-activity relationships in the S-3578 series[J]. Bioorg Med Chem, 2004, 12:4211-4219.
  • 7Gasink L B, Fishrnan N O, Weiner M G, et al. Fluoroquinolone- resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact[J]. Am JMed, 2006, 119(6): 526.
  • 8Tomoyasu I, Shohei H, Yuj I. Phosphonocephem derivatives, process for the preparation of the same and use thereof [P]. US 6417175 B1, 2006-07-09.
  • 9Wiseman L R, Lamb H M. Cefpirome: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia [J]. Drugs, 1997, 54:117-140.
  • 10陈冠容.头孢菌素类抗生素过敏反应与产品质量的关系[J].中国医院药学杂志,2009,29(1):66-67. 被引量:34

共引文献91

同被引文献46

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部